Kamfanin Sichuan Deebio Pharmaceutical Co., Ltd ya karɓi aikin binciken yarda na GMP na hukuma daga Japan PMDA daga 8.25 zuwa 8.26 a cikin 2022. Tawagar binciken GMP ta ƙunshi masu dubawa guda biyu waɗanda ƙwararrun ƙwararrun ƙwararrun tsoffin sojoji suka jagoranta kuma sun gudanar da binciken nesa na kwana biyu.Kwararru na tawagar binciken sun gudanar da cikakken bincike na tsarin kula da ingancin Deebio, tsarin sarrafa kayan aiki, aikin kan layi, kula da dakin gwaje-gwaje, kayan tallafi masu alaka da kayan aiki, da kuma kula da tsarin jama'a.

Ta hanyar binciken, ƙwararrun ƙungiyar binciken sun tabbatar da gaba ɗaya kuma sun amince da tsarin kula da ingancin GMP na Deebio.A ƙarshe, Deebio ya sami nasarar wucewa takardar shedar GMP ta hukuma ta PMDA ta Japan!

PMDA (Hukumar Pharmaceuticals da Medical Devices) wata hukuma ce ta Jafananci da ke da alhakin nazarin fasaha na magunguna da na'urorin likitanci.Yana aiki kama da FDA a Amurka da NMPA a China.

Deebio ya wuce takardar shedar GMP ta EU-GMP da Sinawa.Nasarar wucewar takardar shedar PMDA ta Japan alama ce ta nasara a cikin dabarun duniya na Deebio!